DNA Methylation Analysis from Body Fluids.

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Circulating cell-free DNA (ccfDNA) in body fluids offers a non-invasive source for disease detection, particularly cancer.
• Aberrant DNA methylation in ccfDNA is a key cancer biomarker, but its analysis is hindered by low tumor-derived DNA concentrations.
• Current DNA methylation assays require bisulfite conversion, a harsh process that degrades DNA and necessitates high-purity samples.

Purpose of the Study:

• To develop and describe a protocol for preparing ultra-pure bisulfite-converted DNA from blood plasma and serum.
• To enable sensitive detection of disease-related epigenetic alterations in ccfDNA.
• To facilitate downstream molecular analyses, such as methylation-specific real-time PCR.

Main Methods:

• A protocol for DNA purification from up to 3 ml of blood plasma and serum was established.
• The protocol focuses on preparing bisulfite-converted DNA suitable for molecular analysis.
• Emphasis is placed on achieving ultra-pure DNA to overcome challenges in analyzing low-abundance analytes.

Main Results:

• The described protocol yields ultra-pure bisulfite-converted DNA.
• The purified DNA is well-suited for subsequent molecular biological techniques.
• The method addresses the challenge of low tumor-derived ccfDNA concentration in clinical samples.

Conclusions:

• The developed protocol provides a robust method for preparing high-quality DNA from blood plasma and serum.
• This technique is crucial for advancing the diagnostic utility of DNA methylation analysis in circulating cell-free DNA.
• It facilitates sensitive detection of cancer biomarkers, improving clinical management of malignant diseases.